AMINOPHYLLINE (theophylline ethylenediamine) has been used traditionally in the treatment of bronchospasm associated with asthma, obstructive bronchitis, and emphysema, and its effect on reducing airway obstruction has been clearly shown.' The hemodynamic effects of this agent, however, have not been fully explored. Aminophylline has been shown to reduce the pulmonary artery pressure in patients with cor pulmonale, a change considered to be secondary to pulmonary arteriolar dilatation. 2 In a previous study3 in patients with left ventricular failure, aminophylline was found to reduce the filling pressures of both ventricles and to lower pulmonary artery pressure with a concomitant increase in cardiac output.
No studies have assessed the simultaneous changes in right and left heart pressures in cor pulmonale that occur during an infusion of aminophylline.
This study was undertaken to provide a more complete evaluation of the hemodynamic effect of aminophylline in patients with chronic obstructive pulmonary disease with cor pulmonale as defined by Harvey and Ferrer,4 that is, "cardiac enlargement or failure in association with a disease process known to attack primarily the lungs or some aspect of the act of breathing and in so doing to compromise right ventricular function 
Blood samples from the pulmonary artery and brachial artery were analyzed by the method of Van Slyke and Neill5 for oxygen and carbon dioxide content. Arterial pH was measured with a glass electrode.* The partial pressure of carbon dioxide was calculated from these determinations. Expired air was collected in a Tissot spirometer and analyzed for carbon dioxide and oxygen by the micro-Scholander technique.6 All pressures were measured with Statham strain gauges from a zero pressure level 5 cm below the angle of Louis, and were registered with a photographic recorder.t Systolic and diastolic pressures were calculated by averaging individual systolic and diastolic points over at least two respiratory *Astro-Micro Equipment, Type AME I Radiometer, Copenhagen, Denmrrark. tDR 8 Recorder, Electronics for Medicine, White Plains, New York.
cycles and the mean pressures in the brachial and pulmonary arteries were obtained with an electrical mean. The left and right ventricular end-diastolic pressures were used in place of the mean left and right atrial pressures in the calculation of vascular resistances.
Results
Typical hemodynamic and respiratory responses to aminophylline are shown in figure 1 (case 681) and the data for each patient appear in table 2. Only one set of control pressures, taken during the determination of the pre-infusion cardiac output, is shown for each subject, since these were similar to the other control values. All results obtained during the 30-minute infusion period are shown. Included in this table are a summary and statistical analysis of the various parameters During the control period all patients had pulmonary hypertension. All five patients with clinical evidence of right ventricular failure at the time of study had elevated right ventricular end-diastolic pressures as did one of the patients with previous right ventricular failure. The right ventricular end-diastolic pressure was normal in the remaining three patients. The left ventricular end-diastolic pressure was within normal limits in all patients, and the cardiac index was normal (2.5 to 3.5 L/min/m2) in five and above normal in the remaining four. All patients had elevated arterial carbon dioxide tensions, and all but one (case 848) had lower than normal arterial oxygen saturation; in the one exception it was 93%. During infusion, the pulmonary artery systolic, diastolic, and mean pressures and the right ventricular end-diastolic pressure fell in each patient. These pressure changes were evident within 10 minutes of infusion and reached a plateau within 15 to 20 minutes of the start of the infusion. When the control values were compared to the values during the final 2 minutes of infusion, the average pulmonary artery systolic pressure decreased from 59.6 to 37.9 mm Hg (P < 0.001), the average pulmonary artery diastolic pressure decreased from 27.3 to 18.9 mm Hg (P< 0.001), and the average pulmonary artery mean pressure decreased from 39.4 to 25.4 mm Hg (P<0.001) ( fig. 2 ). The average right ventricular end-diastolic pressure fell from 8.6 to 2.1 mm Hg (P<0.001) ( fig. 3) , and the average left ventricular end-diastolic Circulation, Volume XXXIII, January 1966 pressure decreased from 7.9 to 3.0 mm Hg (P < 0.001). The average brachial artery mean pressure decreased from 95.3 to 85.6 mm Hg (P = 0.02).
The values for oxygen consumption at the termination of the infusion were significantly higher than the control values (P = 0.05). In the six cases in which oxygen consumption was determined halfway through the infusion, it was significantly higher than in these same patients during the control period (P = 0.005). The cardiac index showed no significant change either at 15 or 30 minutes of infusion. The average heart rate rose from 93 beats per minute during the control period to 107 beats per minute at the termination of the infusion (P -0.003), and there was a significant fall in stroke volume (P < 0.001).
The calculated total peripheral resistance did not change, but the decline in pulmonary vascular resistance was highly significant (P =0.003). There was a significant decrease in the stroke wvork of the right ventricle (P < 0.001) and the left ventricle (P =0.005).
During the infusion, the minute ventilation increased from 5.1 to 6.4 L/min/m2 (BTPS) (P = 0.015). The respiratory rate did not change and there was a significant increase in the calculated alveolar ventilation from 2.1 to 2.9 L/min/m2 (P 0.003). This was accompanied by a significant increase in arterial blood pH (P -0.003) and a significant decrease in carbon dioxide tension (P 0.003). The arterial oxygen saturation increased by more than 2% in five patients, decreased by more than 2% in two patients, but the average change for the entire group was not statistically significant.
Discussion
Hemodynamic observations during the preinfusion period were typical of those in cor pulmonale with normal left ventricular enddiastolic pressure, pulmonary hypertension, and a normal or elevated cardiac index.7 The alveolar ventilation was low, and this was associated with carbon dioxide retention and arterial oxygen unsaturation in all but one patient.
Circulation, Volume XXXIII, January 1966 Infusion of aminophylline produced a small but significant fall in left ventricular enddiastolic pressure, a marked decline in the pulmonary artery mean pressures, but no change in cardiac index. If there were no associated changes in pulmonary arteriolar tone, the fall in pulmonary arterial and venous pressures would allow the resistance vessels of the lung to collapse, a situation that would increase pulmonary vascular resistance. 8 The fact that the calculated resistance actually decreased indicates pulmonary arteriolar dilatation or at least a reduction in vascular tone. Pulmonary vascular resistance may also be lowered by reductions in endobronchial pressure,9 and aminophylline, by reducing airway obstruction,' could produce these effects. No data are available in this study, but in the absence of gross bronchospasm, the changes in endobronchial pressure probably would be too small to account for the observed changes in resistance.
Storstein, Helle, and Rokseth'0 studied patients with various forms of heart and lung disease, with and without evidence of cardiac failure. They observed a decrease in the pulmonary artery mean pressures without change in the pulmonary artery wedge pressure during infusion of aminophylline and concluded that the drug induced pulmonary arteriolar dilatation. Their finding of a constant wedge pressure during the aminophylline infusion is contrary to our present observations and to our previous findings in patients with left ventricular failure. The reason for this discrepancy is not clear, but their patients suffered from a variety of pulmonary and cardiac diseases and the pulmonary artery wedge technic is a less reliable method for the estimation of mean left atrial pressure than is the direct measurement of left ventricular end-diastolic pressure.
Zimmerman2 observed reductions in the pulmonary artery pressures from aminophylline during paroxysms of bronchial asthma and in chronic cor pulmonale. He concluded that aminophylline produced pulmonary arteriolar dilatation, but he did not include determinations of wedge pressures or cardiac output during the infusion of aminophylline to substantiate this conclusion.
In animal studies, Borst, Berglund, and Mc-Gregor" and Barer and Gunning12 obtained evidence suggesting that the fall in pulmonary artery pressure produced by aminophylline was due to pulmonary arteriolar dilatation. On the other hand, Harasawa and Rodbard13 in studies on anesthetized dogs concluded that the changes in pulmonary artery pressure induced by aminophylline were related to changes in pulmonary blood flow with no direct effect on pulmonary vasctular tone.
The changes in this study suggesting pulmonary arteriolar dilatation or a reduction in pulmonary arteriolar tone are probably due to a direct vasodilating effect of aminophylline. It has been shown, however, that a reduction in H+ concentration is associated with pulmonary arteriolar dilatation in patients with chronic pulmonary disease.14 In this study, however, there was no good correlation between the changes in arterial pH or PaCO2 and the reduction in pulmonary artery pressures.
Aminophylline has been shown to have an inotropic effect in dogs,'5 but we could not demonstrate this action in this study as the decline in the end-diastolic pressures was accompanied by a reduction in the stroke work of both ventricles.
Aminophylline is a known respiratory stimulant,16 and its effect on increasing minute ventilation and alveolar ventilation was confirmed in this study. The increase in alveolar ventilation produced a significant decrease in arterial carbon dioxide tension, but no consistent change in arterial oxygen saturation, an observation also made by Christensen and co-workers,'7 Storstein and associates,'0 and more recently by Daly and Howard.18 The increase in arterial blood pH would be expected to increase arterial oxygen saturation by shifting the oxyhemoglobin dissociation curve to the left. The failure to increase saturation consistently in spite of this increase in pH and the increase in alveolar ventilation indicates that aminophylline does not always improve the abnormal ventilation-perfusion ratios present in chronic obstructive pulmonary disease.
The dose of aminophylline administered in this study was greater than that used in clinical situations. The changes induced by the drug, however, were evident after 15 minutes of infusion when 0.5 g of aminophylline had been infused. Summary Nine patients with cor pulmonale due to chronic obstructive pulmonary disease were studied by means of right and left heart catheterization. Hemodynamic and respiratory observations were made during a control period and during the infusion of 1 g of aminophylline.
Aminophylline produced a significant reduction in mean pulmonary artery pressure from 39.4 to 25.4 mm Hg, in right ventricular end-diastolic pressure from 8.6 to 2.1 mm Hg, in left ventricular end-diastolic pressure from 7.9 to 3.0 mm Hg, and in brachial artery mean pressure from 95.3 to 85.6 mm Hg. The heart rate and oxygen consumption increased, but there was no change in cardiac index. The alveolar ventilation increased significantly from 2.1 to 2.9 L/min/m2 (BTPS).
Evidence is presented to suggest that the decrease in pulmonary artery pressure was due to pulmonary arteriolar dilatation.
